Theravance Biopharma Inc
TBPH
Market Cap$485.84M
Close$
$10.75
8.8% upside
Current Fair Value
8.8% upsideUndervalued by 8.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $485.84 Million |
|---|---|
| Enterprise Value | $507.45 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1 |
| Beta | 0.25 |
| Outstanding Shares | 49,038,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -9.81 |
|---|---|
| PEG | -23.42 |
| Price to Sales | 9.88 |
| Price to Book Ratio | 3.29 |
| Enterprise Value to Revenue | 8.03 |
| Enterprise Value to EBIT | -12.83 |
| Enterprise Value to Net Income | -11 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | 0.24 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Theravance Biopharma Inc
CEO: Rick Winningham